|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-7-15
|
|
pubmed:abstractText |
Administering proton pump inhibitors (PPI) intravenously (iv) after endoscopic treatment of bleeding peptic ulcers reduces the incidence of rebleeding, the need for operative procedures, and hospitalizations. We assessed the cost implications of iv PPI initiated in all patients presenting to the emergency department (ED) with signs of upper gastrointestinal (UGI) bleeding.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1098-3015
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
457-65
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12859587-Anti-Ulcer Agents,
pubmed-meshheading:12859587-Costs and Cost Analysis,
pubmed-meshheading:12859587-Drug Costs,
pubmed-meshheading:12859587-Emergency Service, Hospital,
pubmed-meshheading:12859587-Female,
pubmed-meshheading:12859587-Hospital Costs,
pubmed-meshheading:12859587-Humans,
pubmed-meshheading:12859587-Infusions, Intravenous,
pubmed-meshheading:12859587-Length of Stay,
pubmed-meshheading:12859587-Male,
pubmed-meshheading:12859587-Middle Aged,
pubmed-meshheading:12859587-Monte Carlo Method,
pubmed-meshheading:12859587-Peptic Ulcer Hemorrhage,
pubmed-meshheading:12859587-Proton Pumps,
pubmed-meshheading:12859587-Treatment Outcome,
pubmed-meshheading:12859587-United States
|
|
pubmed:articleTitle |
Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
|
|
pubmed:affiliation |
Occam Research & Consulting Inc, Vancouver, British Columbia, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
